Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.8.0.1
Accrued Expenses
3 Months Ended
Mar. 31, 2018
Accrued Liabilities [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
4. Accrued Expenses
 
Accrued expenses consist of the following: 
 
 
 
March 31,
2018
(unaudited)
 
December 31,
2017
 
Clinical Trials
 
$
815,921
 
$
807,322
 
Payroll and Benefits
 
 
333,796
 
 
788,551
 
Professional Fees
 
 
195,374
 
 
149,273
 
Consulting
 
 
54,633
 
 
57,487
 
Short-Term Portion of Capital Lease Obligation
 
 
9,624
 
 
11,214
 
Total Accrued Expenses
 
$
1,409,348
 
$
1,813,847